Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) issued and outstanding.
Appears in 101 contracts
Samples: Underwriting Agreement (Medigus Ltd.), Underwriting Agreement (Nano Dimension Ltd.), Underwriting Agreement (Nano Dimension Ltd.)
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (including Ordinary Shares underlying ADSs, but excluding treasury shares, if any) issued and outstanding.
Appears in 49 contracts
Samples: Biodexa Pharmaceuticals PLC, Biodexa Pharmaceuticals PLC, Biodexa Pharmaceuticals PLC
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares or ADSs, as applicable, deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares or ADSs, as applicable, (excluding treasury shares, if any) issued and outstanding.
Appears in 21 contracts
Samples: Underwriting Agreement (The9 LTD), Scinai Immunotherapeutics Ltd., Scinai Immunotherapeutics Ltd.
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADSa share, as the case may be. For purposes of this Section 3, the number of Ordinary Shares or ADSs, as applicable deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares or ADSs, as applicable (excluding treasury shares, if any) issued and outstanding.
Appears in 8 contracts
Samples: Addex Therapeutics Ltd., Addex Therapeutics Ltd., Addex Therapeutics Ltd.
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADSa share, as the case may be. For purposes of this Section 3, the number of ADSs and/or Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of ADSs or Ordinary Shares Shares, as applicable (excluding treasury shares, if any) issued and outstanding.
Appears in 8 contracts
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares or ADSs deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares or ADSs, as applicable, (excluding treasury shares, if any) issued and outstanding.
Appears in 7 contracts
Samples: RedHill Biopharma Ltd., RedHill Biopharma Ltd., RedHill Biopharma Ltd.
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an Ordinary Share or ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) issued and outstanding.
Appears in 6 contracts
Samples: Quoin Pharmaceuticals, Ltd., Quoin Pharmaceuticals, Ltd., Quoin Pharmaceuticals, Ltd.
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Class A Shares or ADSs, as applicable deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Class A Shares or ADSs, as applicable (excluding treasury shares, if any) issued and outstanding.
Appears in 5 contracts
Samples: BIT Mining LTD, BIT Mining LTD, BIT Mining LTD
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADSADS or Ordinary Share, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) issued and outstandingoutstanding (including Ordinary Shares represented by ADSs but excluding Ordinary Shares held by the Depositary for future sale and issuance).
Appears in 5 contracts
Samples: ASLAN Pharmaceuticals LTD, ASLAN Pharmaceuticals LTD, ASLAN Pharmaceuticals LTD
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, ADS as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (including Ordinary Shares underlying ADSs, but excluding treasury shares, if any) issued and outstanding.
Appears in 4 contracts
Samples: Warrant Issuance Agreement (Kazia Therapeutics LTD), Kazia Therapeutics LTD, Kazia Therapeutics LTD
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (including Ordinary Shares underlying ADSs but excluding treasury shares, if any) issued and outstanding.
Appears in 4 contracts
Samples: Nano Dimension Ltd., Nano Dimension Ltd., Nano Dimension Ltd.
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADSa share, as the case may be. For purposes of this Section 3, the number of ADSs or Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of ADSs or Ordinary Shares (excluding treasury sharesADSs or Ordinary Shares, if any, as applicable) issued and outstanding.
Appears in 2 contracts
Samples: Purchase Agreement (Kazia Therapeutics LTD), Kazia Therapeutics LTD
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADSa share, as the case may be. For purposes of this Section 3, the number of Ordinary Shares and/or ADSs deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares and/or ADSs (excluding treasury shares, if any) issued and outstanding.
Appears in 2 contracts
Samples: SOS LTD, Yoshitsu Co., LTD
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Ordinary Shares (including Ordinary Shares underlying ADSs, but excluding treasury shares, if any) issued and outstanding.
Appears in 2 contracts
Samples: Tiziana Life Sciences PLC, Tiziana Life Sciences PLC
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADSa share, as the case may be. For purposes of this Section 3, the number of Ordinary Class A Shares or ADSs, as applicable deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Class A Shares or ADSs, as applicable (excluding treasury shares, if any) issued and outstanding.
Appears in 2 contracts
Samples: Onion Global LTD, Onion Global LTD
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADSa share, as the case may be. For purposes of this Section 3, the number of ADSs or Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of ADSs or Ordinary Shares (excluding treasury shares, if any) issued and outstanding.
Appears in 1 contract
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (including Ordinary Shares underlying the Warrant ADSs, but excluding treasury shares, if any) issued and outstanding.
Appears in 1 contract
Samples: Advanced Human Imaging LTD
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADSa share, as the case may be. For purposes of this Section 3, the number of Ordinary Shares or ADS deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) or ADS issued and outstanding.
Appears in 1 contract
Samples: Fresh2 Group LTD
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of an ADSOrdinary Share, as the case may be. For purposes of this Section 3, the number of Ordinary Shares or ADSs, as applicable deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares or ADSs, as applicable (excluding treasury shares, if any) issued and outstanding.
Appears in 1 contract
Samples: Stealth BioTherapeutics Corp
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th 1/2000th of an ADS, as the case may be. For purposes of this Section 3, the number of Ordinary Shares deemed to be issued and outstanding as of a given date shall be the sum of the number of Ordinary Shares (excluding treasury shares, if any) issued and outstanding.
Appears in 1 contract
Samples: Akari Therapeutics PLC
